The influence of a substituent at the hydroximo function of the lactam analogue 1 on the inhibition of β‐ and α‐glucosidases is evaluated. In contrast to 1, the O‐alkyl oximes 5, 6, 9, and 10 are selective inhibitors of β‐glucosidases. Alkylation of the D‐gluconohydroximo‐1,5‐lactam 19 with the triflate 12, or condensation of the thiogluconolactam 20 with the hydroxylamines 14 or 18 afforded the benzylated cellobioside analogues 21 and 23, respectively. The O‐alkyl oximes 33 and 39 were prepared similarly (Scheme 3). Deprotection afforded the cellobioside analogues 5 and 6, and the O‐alkyl oximes 9 and 10. The lactam O‐alkyl oximes 5, 6, 9, and 10 are strong inhibitors of the β‐glucosidase from C. saccharolyticum (IC50=0.3 – 8 μM) and, with exception of the dodecyl analogue 9 (IC50=2 μM), moderate‐to‐weak inhibitors of β‐glucosidases from sweet almond (IC50=60 – 1000 μM; see Table). In contrast to the strong inhibition of α‐glucosidase from brewer's yeast by 1 (Ki=2.9 μM), the ethers 5, 6, and 10 are weak inhibitors of this enzyme (IC50 between 2500 and >5000 μM). Similarly, the D‐galactohydroximo‐1,5‐lactam 7 is a potent inhibitor of the α‐galactosidase from coffee beans and of the β‐galactosidases from bovine liver and E. coli (Ki=5, 10, and 0.1 μM, resp.), while the lactoside analogue 8 is a strong inhibitor of the E. coli β‐galactosidase (Ki=0.1 μM), but a moderate‐to‐weak inhibitor of coffee‐bean α‐galactosidase and bovine‐liver β‐galactosidase (Ki=250 μM and IC50=2500 μM, resp.). The galacto‐configured lactam oximes 7 and 8 are good inhibitors of the β‐glucosidase isolated from C. saccharolyticum (Ki=2.5 and 3.3 μM, resp.).